AMENDED: Bank covenant waiver and trading update
19 December 2024
Bank covenant waiver and trading update
Comvita Limited (NZX:CVT) provides an update on its Q2 FY25 covenants and underlying trading performance as
the close of half year (H1FY25) approaches.
Bank Covenant update
Comvita confirms that its bank syndicate has a revised covenant package for its Q2 FY25 covenants (to be tested as
at 31 December 2024).
As we announced at our Annual Shareholder Meeting, we do not consider that our present covenant structure is
appropriate in the current circumstances. Without further covenant relief or amendment of our covenant
structure, our present covenants (to be tested in Q3 and Q4) would not be met. However, we remain in
productive discussions with our bank syndicate and we expect those discussions to continue as we progress
through the balance of the financial year.
Half-year trading update
Comvita has broadly maintained its revenue through the first half of the year, despite a challenging global
macroeconomic environment, suppressed consumer spending, and in-market deep discounting by entry level
honey labels. The impact of aggressive competition and the associated pressure on gross margin will result in
NPAT for H1 in the order of -$6.5M to -$7.5M (H1FY24: -$3.2M loss).
Brett Hewlett, CEO comments “We continue to make progress on our cost out and restructuring initiatives, with
the majority of that benefit falling into the second half. We have made the decision to revert to distributor models
in UK and Europe. We are significantly simplifying our operations in North America and in China and have
disestablished the two Regional CEO roles. In total, the Leadership Team will be reduced by four. Structural
changes have already been implemented in our Forest management and Apiary business subsidiaries ahead of this
season that are expected to provide greater efficiencies in the short to near term. The annualised benefit for these
structural changes will be realised in FY26.”
“Progress is also being made in relation to inventory levels. Comvita’s inventory levels will be circa $125M
(H1FY24: $143M). We expect a net positive operating cash flow over our first half. Our net debt is expected to
remain flat against pcp, with debt reduction remaining a priority for the second half.”
Comvita will provide a more fulsome update on its cost out and restructuring initiatives, and progress on strategic
initiatives, when it reports its half year results in late-February.
Bridget Coates
Board Chair
Brett Hewlett
CEO
ENDS.
For more information, please contact:
Brett Hewlett | Comvita
Mobile: +61 21 740160
Email: brett.hewlett@comvita.com
Background information
Comvita (NZX:CVT) was founded in 1974/5, with a purpose to heal and protect the world through the natural
power of the hive. With a team of 550+ people globally, united with more than 1.6 billion bees, we are the global
market leader in Mānuka honey and bee consumer goods. Seeking to understand, but never to alter, we test and
verify all our bee-product ingredients are of the highest quality in our own government-recognised and accredited
laboratory. We are growing scientific knowledge on Mānuka trees, the many benefits of Mānuka honey and
propolis and bee welfare. We have planted millions of native trees, improving our natural ecosystems and
biodiversity, and mitigating climate change in conjunction with our focus on carbon emissions reduction, while
helping ensure the supply of high quality Mānuka honey. In 2023 Comvita was certified B Corp, a global community
of like-minded companies that strive to balance profit with purpose, seeking to use business as a force for good.
Comvita has operations in Australia, China, North America, Southeast Asia, and Europe – and of course, Aotearoa
New Zealand, where our bees are thriving.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.